MECFC 2019
3rd Annual Middle East
Cystic Fibrosis Conference
Istanbul, Turkey
March 21st, 22nd and 23rd
March 21
MECFA- Road to the Future - Christine Noke, MECFA CEO, USA
European Standards of Care - How did we make and maintain them? - Carlo Castellani, ITA
Survey of CF Care in the Middle East - Results - Hussein Al Kindi, OMN
Developing CF Centers in the region - The MaMi Project - Samya Nasr, USA
Combating cross contamination in clinical care - the rules of hygiene - Bulent Karadag, TUR
Recent Advances in CF CRMS/CFSPID - Carlo Castellani, ITA
Update on ongoing studies in CF - Samya Nasr, USA
Lobbying for CF care in the Middle East - Ibrahim Al Janahi, QAT
Lobbying for CF Care in the Middle East - İlknur Özgür Görgün - President of KIFDER, TUR
CF Genetics in the Middle East - Hussein Al Kindi, OMN
CF Genetics in the Middle East - Atqah Abdulwahab, QAT
March 22
Therapeutic drug monitoring and pharmacokinetics in CF - Daniel Touw, NLD
The important role of patient organizations: CF Europe - Jacquelien Noordhoek, NLD
Update on new drugs for CF and the Rainbow Project - Hendrikus Heijerman, NLD
CF In the Middle East - CF Iran -Mohammedreza Modaresi, IRN
CF In the Middle East - CF Egypt-Nader Fasseeh, EGY
CF In the Middle East - CF in Omani and Pakistan/Indian Patients - Hussein Al Kindi, OMN
Home-made therapies for CF; a recipe for lower cost treatments - Daniel Touw, NLD
CF-IDEA, A non-profit solution to high cost therapies - Christine Noke, USA
Physiotherapy in CF-US and Middle East Experience - Christopher Tapley, USA
Physiotherapy in CF-US and Middle East Experience - Özge Keniş, TUR
March 23
CF in Adults - What is different? - Hendrikus Heijerman, NLD
CF Adult Care, challenges in the Middle East - Derya Kocakaya, TUR
Adult Care, challenges in the Middle East - Mona Al Lingawi, QAT
Honorary International Speakers

Netherlands

USA

Czech Republic

Italy

Germany

USA

Netherlands

USA

USA

Netherlands

USA
Honorary Regional Speakers

Turkey

Palestine
